SCHEMBL3924366

SCHEMBL3924366

CNc1ccc(CN2C[C@@H](C)[N+](C(=O)[O-])(C(C)(C)C)[C@@H](C)C2)cc1

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.39
ALDH1A1 P00352 2/20 0.39
S1PR1 P21453 3/20 0.38
S1PR5 Q9H228 3/20 0.38
RAB9A P51151 4/20 0.36
MAPT P10636 3/20 0.36
TP53 P04637 2/20 0.36
PKM P14618 1/20 0.36
NPC1 O15118 2/20 0.36
POLB P06746 1/20 0.36
MLNR O43193 1/20 0.36
CYP3A4 P08684 1/20 0.36
HRH3 Q9Y5N1 2/20 0.35
HRH4 Q9H3N8 1/20 0.35
TNIK Q9UKE5 1/20 0.34
FAAH O00519 1/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
LMNA P02545 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3921210 1.00 KDM4E (0.39) KDM4EALDH1A1S1PR1S1PR5RAB9A
SCHEMBL3913756 0.85 GBA1 (0.41) ALDH1A1S1PR1S1PR5HRH3HRH4
SCHEMBL3927020 0.82 GBA1 (0.48) KDM4EALDH1A1RAB9AMAPTNPC1
SCHEMBL3921687 0.82 GBA1 (0.48) KDM4EALDH1A1RAB9AMAPTNPC1
SCHEMBL3914828 0.81 DRD2 (0.39) KDM4EALDH1A1S1PR1S1PR5RAB9A
SCHEMBL4596731 0.76 MLNR (0.69) MLNRCYP3A4
SCHEMBL2766832 0.71 KDM4E (0.43) KDM4EALDH1A1S1PR1S1PR5RAB9A
SCHEMBL377504 0.71 PTPN2 (0.39) KDM4EALDH1A1RAB9AMAPTTP53
SCHEMBL3911225 0.67 MLNR (0.34) S1PR1S1PR5TP53MLNRFAAH
SCHEMBL4597553 0.67 SMN1; SMN2 (0.39) KDM4EALDH1A1RAB9AMAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2041093-A1 PIPERAZINYL DERIVATIVES USEFUL IN THE TREATMENT OF GPR38 RECEPTOR MEDIATED DISEASES Glaxo Group Limited (GB) 2009-04-01 EP disclosed
WO-2008000729-A1 PIPERAZINYL DERIVATIVES USEFUL IN THE TREATMENT OF GPR38 RECEPTOR MEDIATED DISEASES GLAXO GROUP LIMITED (GB) 2008-01-03 WO disclosed